Kingtone Wirelessinfo Solution Holding Ltd Reports Fiscal Year 2013 Financial Results; Provides Fiscal Year 2014 Revenue and Net Income Guidance. FY13 Revenues Up 696.8% to $11.6 million from $1.5 million in the Prior Year. FY13 Gross Profit Up 527.7% to $1 million from $0.2 million loss in the Prior Year. FY13 Basic and Diluted Loss Per Share Up to $3.65 from Loss Per Share of $6.40 in the Prior Year Kingtone Wirelessinfo Solutions Hldg Ltd (NASDAQ:KONE) stock opened at $7.13 in last trading session, and closed at $12.30, trading in the range of $6.76 – $16.74. The stock showed a positive weekly performance of 217.01%.
China Advanced Constructn Mtrls Grp Inc (NASDAQ:CADC) shares closed at $7.50 on last trade day, by gaining 50.30%. Stock 52 week range is $2.65 – $9.24. Company’s market capitalization is $11.15 billion. China Advanced Constructn Mtrls Grp Inc (NASDAQ:CADC) is a holding company. The Company’s business operations are conducted through its wholly-owned subsidiaries BVI-ACM and China-ACMH, and its variable interest entity Xin Ao. The Company engages in the production of construction materials for infrastructure, commercial and residential developments. The Company is primarily focused on engineering, producing, servicing, delivering and pumping a range of ready-mix concrete materials for construction projects.
Stemline Therapeutics Inc (NASDAQ:STML) Average Recommendation is Buy with Average Target Price $55.60.Stemline Therapeutics Inc (NASDAQ:STML) stock surged 39.50% and finished the last session at $30.44. The EPS of the stock remained -2.28. Company’s market capitalization is $392.85 billion. Stemline Therapeutics, Inc. (Stemline) is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics that target both cancer stem cells (CSCs) and tumor bulk. The Company is developing two clinical-stage product candidates, SL-401 and SL-701, for which it holds global marketing rights.
GenVec Inc (NASDAQ:GNVC) stock opened at $2.85 in last trading session and closed at $3.63. The 52 week range of the stock is $0.25 – $3.80 and the day range was $2.85 – $3.80. GenVec Inc (NASDAQ:GNVC) develops gene-based pharmaceuticals and therapies for the treatment of major medical needs. The Company combines its patented gene transfer technologies with proprietary therapeutic genes to create product candidates that address needs in the areas of cardiovascular disease, cancer and other therapeutic areas.
China Advanced Constructn Mtrls Grp Inc (NASDAQ:CADC)
Leave a Reply